Feasibility and pilot testing of an interactive web-based decision-making programme on relapse management for people with multiple sclerosis (POWER@MS2)

Authors :: Wenzel, L
Scheiderbauer, J
Meyer, B
Thale, F
Haas, J
Kretzler, M
Icks, A
Friede, T
Heesen, C
Köpke, S
Rahn, AC
Source :: 19. Deutscher Kongress für Versorgungsforschung (DKVF); 20200930-20201001; sine loco [digital]; DOC20dkvf229 /20200925/
Publication Year :: 2020
Publisher :: German Medical Science GMS Publishing House, 2020.
Abstract: Background: In about 85% of cases, multiple sclerosis (MS) manifests with a relapsing-remitting disease course. In Germany, intravenous therapy with high-dose corticosteroids is the standard treatment for acute relapses. Informed treatment decisions on relapse management are required as corticosteroid[for full text, please go to the a.m. URL]<br />19. Deutscher Kongress für Versorgungsforschung (DKVF)

Language :: English
Database :: OpenAIRE
Journal :: 19. Deutscher Kongress für Versorgungsforschung (DKVF); 20200930-20201001; sine loco [digital]; DOC20dkvf229 /20200925/
Accession number :: edsair.doi.dedup.....30a2d2b44adec66636407311cfef43f3
Full Text :: https://doi.org/10.3205/20dkvf229

Full Text Access

Tools